Greg Smith talks about a massive acquisition being made by biotech giant CSL, which is the 4th biggest M&A deal in Australia this year and the largest rights issue in Aussie corporate history. He also reviews Air New Zealand's liquidity top up from the government, and the implications of strong US producer price index numbers.

For more market insights and for our terms and conditions, visit www.devonfunds.co.nz